Empagliflozin Reduces Liver Fat Content Regardless of T2DM, Study Finds
Findings were presented at The Liver Meeting 2023 from the American Association for the Study of Liver Diseases and showed empagliflozin reduced liver fat content in both patients with T2DM and nondiabetic patients.
Source: hcplive.com